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2006
Legislation passed








dispenser to upload data to




Joint revised Pain Management
Guidelines approved by the SC
State Medical Board, SC Board of
Dentistry, and SC Board of Nursing
consider registration and utilization
of SCRIPTS "mandatory for
prescribers to provide safe,
adequate pain treatment."
December 2014
State Plan to Prevent
and Treat Prescription
Drug Abuse
The Governor's Prescription Drug
Abuse Prevention Council released




SCRIPTS switched vendors and
started online registration for users,
registration of delegate accounts,
and online password resets.
I. Executive Summary
     The South Carolina Prescription Monitoring Program (SC PMP)
became fully operational on February 1, 2008. The purpose of the PMP
is to improve the state’s ability to identify and stop diversion of
prescription drugs in an efficient and cost-effective manner that will
not impede the appropriate medical utilization of licit controlled
substances. This summary highlights trends in (1) prescription and
patient volume and (2) prescriber and pharmacist utilization from 2015
to 2020.  The full report provides details regarding the prescribing
patterns of SC prescribers.
     In 2020, the number of controlled substance prescriptions 
dispensed in SC was 9,358,829. Fortunately, this number has declined
by 16.78% since 2015 (Figure 1). Benzodiazepines and opioids have also
continued to decrease since 2015 (Figure 2). However, stimulants have
increased by 12.23% from 2015 to 2020. For further details regarding
the characteristics of the controlled substances dispensed in SC,
please see Table 1.




























First two integrations of SCRIPTS
into Emergency Departments'
electronic health records were
completed.
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Mandated prescriber use of PMP,
for practitioners to check PMP
before issuing a CII





Sent out first round of quarterly




Limited initial opioid prescriptions
for acute pain management or
postoperative pain management to
not exceed a seven-day supply,
except when clinically indicated.
PMP began using NarxCare.




























Required veterinarians to report all
CII-CIV daily.
Turned on clinical alerts to alert
providers of patients seeing
multiple providers, patients
receiving an opioid prescription
that had an MME>90, or if a patient











SCRIPTS users can access data
from 44 other state PMPs, plus the
District of Columbia, Puerto Rico













2016 2017 2018 2019 2020
11,153,135 10,626,721 9,861,690 9,600,903 9,358,829
Table 1. Characteristics of controlled substance prescriptions
dispensed in SC, 2015 - 2020
1,927,722 1,902,724 1,831,052 1,706,888 1,644,259 1,556,625
65,261 69,326 66,711 64,576 65,844 67,773
1,812 2,151 1,796 1,850 1,713 1,793
Prescription Quantity 620,492,739 607,661,115 571,150,075 512,987,076 479,033,085 466,577,961
1
1 Prescription quantity only includes controlled substances that were capsules or tablets.
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     A goal of the PMP is to inform
prescribers about possible drug misuse at
the time of prescribing. Frequent use of
the PMP has been shown to aid
prescribers in detecting likely prescription
drug abusers and multiple
provider episodes.  We defined
multiple provider episodes as visiting 10
or more prescribers during a 90-
day period.  From 2015 to 2020, there was
an 88.51% decrease in the number of
patients that filled a prescription in





































     Appriss, SC’s current vendor,
operates both PMP AWARxE
and Gateway. PMP AWARxE 
users create profiles validated
against the state licensing
system and must log into the
web portal to perform a patient
search. While this allowed
licensed users to easily access
PMP data, having to log in each
time to view PMP data proved to
be a major barrier. Therefore, in
2013, the SC PMP was awarded a
grant by the Substance Abuse
and Mental Health Services 
Administration (SAMSHA)  to
integrate the PMP into healthcare systems, so that users no longer have to sign in each time to access PMP
data.  These integrations are enabled using an Application Protocol Interface (API) known as Gateway.  This
translation service connects health information systems to the PMP. In September 2015, the first two
integrations were completed. Since that time, the total number of PMP queries conducted by pharmacists
and prescribers has increased by 646.81% from 2016 to 2020.  Since not all health systems are integrated,
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     The continual efforts of
the Bureau of Drug Control
to create an efficient and
streamlined program
have increased the number
of frontline workers that use




(Figure 5). These efforts will
continue to reduce the
number of people who
misuse, abuse, or overdose
on these substances and
ensure that patients have
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II. Introduction
     In 2006, the SC PMP, known as SCRIPTS (South Carolina Reporting & Identification Prescription Tracking
System), was mandated by the South Carolina General Assembly. S.C. Code Ann. § 44-53-1640 to require in-
state and nonresident South Carolina licensed dispensers to submit data on Schedule II - IV controlled
substances to the Bureau of Drug Control, Department of Health and Environmental Control (DHEC). For
















Date the prescription was issued by prescriber
Date the prescription was dispensed
If the prescription was a refill or new prescription
Quantity dispensed
Estimated days of supply
     A promising strategy for addressing the prescription opioid overdose epidemic is to improve the use of
the PMP.  The PMP is a state-run database that collects patient-specific prescription information at the
point of dispensation. This report focuses on the prescribing patterns of SC prescribers and provides details
for the following drug classes: benzodiazepines, opioids, and stimulants. These drug classes were identified
based on the Center for Disease Control and Prevention (CDC) definition.
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III. Benzodiazepines
     Benzodiazepines are a class of
central nervous system
depressant drugs approved to
treat a diverse set of medical
conditions, which include
anxiety, insomnia, seizures, and
acute alcohol withdrawal. This
section reports on
benzodiazepines that were
prescribed by a SC provider and
dispensed in SC. In 2020, the
most common prescriptions




























Figure 6.  Number of filled benzodiazepine prescriptions prescribed by
SC prescribers over time
13.71% decline
since 2015
2020, the number of dispensed benzodiazepine prescriptions decreased by 13.71% (2,543,840 to 2,195,204,
respectively) (Figure 6). Additionally, the total quantity of benzodiazepine prescriptions decreased by 20.81%
during the same time period (Figure 7).






















Figure 7.  Total prescription quantity for benzodiazepines over time 1
Prescription quantity is defined as a benzodiazepines in a capsule or tablet form.1 7
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     In 2020, the average age of patients receiving benzodiazepines from SC prescribers was 56. While SC has
seen a decline over the years in benzodiazepine prescriptions among several age groups, from 2015 to
2020, there was over a 10% increase in prescriptions among those 18-24 and 25-34 years of age (Figure 8).
Additionally, more females than males received a benzodiazepine prescription in 2020 (279,270 versus
142,908, respectively).  The number of individuals that filled a benzodiazepine prescription decreased by
more than 10% among both males and females from 2015 to 2020. From 2015 to 2020, SC prescribers
prescribed fewer benzodiazepine prescriptions among all payment types except for Medicaid and Workers
Comp (Figure 9). With the exception of controlled substance prescriptions dispensed under a commercial
insurance payment provider, Medicare patients filled the most benzodiazepine prescriptions compared to
any other insurance type in 2020. The number of patients filling benzodiazepine prescriptions from SC
prescribers has decreased for both in-state and out-of-state patients from 2015 to 2020. In 2020, the number
of patients with a SC address filling a benzodiazepine prescription in SC and from a SC prescriber was
425,077, while the number of patients with an address outside of SC was 9,212.
3.2 Patient Demographics






















Figure 8. Number of filled benzodiazepine prescriptions prescribed by
SC prescribers by patient age 1
Age is self-reported from the patient to the pharmacist.  Please note that if age was
unknown, it was not included in this analysis.  The blue line indicates an increase in the
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Figure 9. Number of filled benzodiazepine prescriptions prescribed by
SC prescribers by patient insurance type 1
Insurance type is self-reported from the patient to the pharmacist.  Please note that if the
insurance type was not specified it was not included in this analysis.  Private pay refers to
those that did not pay with insurance.  The blue line indicates an increase in the number of
prescriptions from 2015, while a gray line indicates a decrease.
1
     The average rate of dispensed benzodiazepines prescriptions prescribed by SC prescribers has declined
from 520.3 per 1,000 people in 2015 to 426.4 per 1,000 people in 2020. From 2015 to 2020, the rate of
benzodiazepine prescriptions shifted from the Upstate region of SC to the Midlands and Low Country
regions. The rate of benzodiazepine prescriptions was higher than the SC rate in Kershaw and Bamberg
county in 2020, while this was not the case in 2015 (Figure 10 and 11). Additionally, from 2015 to 2020, the
number of benzodiazepine prescriptions increased more than 10% in Calhoun and Bamberg county, while
decreasing in 38 other counties in SC over time. In 2020, Charleston, Greenville, Florence, Darlington, and
Lexington had the highest rate of dispensed benzodiazepine prescriptions.
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Figure 10.  Rate of benzodiazepine prescriptions per 1,000 residents by prescriber county for 2015
Figure 11.  Rate of benzodiazepine prescriptions per 1,000 residents by prescriber county for 2020
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IV. Opioids
     Opioids are a class of drugs
used to treat pain and is often
prescribed after surgery, an
injury, or for a variety of other
health conditions.  This section
reports on opioids dispensed in
SC and prescribed by a SC
prescriber. In 2020, the most
common prescriptions filled of





HCL/naloxone HCL. From 2015 to
2020, the number of dispensed
4.1 Overview


























opioid prescriptions decreased by 26.11% (4,619,103 to 3,413,038, respectively) (Figure 12). Additionally, the total
quantity of opioid prescriptions decreased by 34.33% during the same time period (Figure 13).






















Figure 13.  Total prescription quantity for opioids over time 1
Prescription quantity is defined as an opioid in a capsule or tablet form.1
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     The CDC recommends
prescribing the lowest effective
opioid dosage possible.  To
quantify an opioid’s dosage,
morphine milligram equivalents
(MME) are used.  Daily MME is a
metric used to gauge overdose
potential and identify patients
that may benefit from closer
monitoring.  From 2015 to 2020,
the average daily MME
prescribed by SC prescribers
decreased by 21.84% (43.39 to
33.91, respectively) (Figure 14).






















Figure 14. Average daily MME for opioids over time
4.2 Patient Demographics
     In 2020, the average age of patients receiving opioids from SC prescribers was approximately 53. SC has
seen a decline over time in opioid prescriptions among all age groups (Figure 15). Additionally, more females
than males received an opioid prescription in 2020 (500,825 versus 371,210, respectively). However, the
number of individuals that received an opioid prescription decreased by more than 25% among both males
and females from 2015 to 2020. From 2015 to 2020, SC prescribers prescribed fewer opioids among all
payment types. With the exception of controlled substances prescriptions dispensed under a commercial
insurance payment provider, Medicare continues to be one of the top forms of payment for patients
receiving opioids (Figure 16). The number of patients receiving opioid prescriptions from SC prescribers has
decreased for both in-state and out-of-state patients from 2015 to 2020. In 2020, the number of patients
with a SC address receiving an opioid prescription in SC from a SC prescriber was 861,491, while the number
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Figure 15. Number of filled opioid prescriptions prescribed by SC
prescribers by patient age 1
Age is self-reported from the patient to the pharmacist.  Please note that if age was
unknown, it was not included in this analysis.  The blue line indicates an increase in the
number of prescriptions from 2015, while a gray line indicates a decrease.
1























Figure 16. Number of filled opioid prescriptions prescribed by SC
prescribers by patient insurance type 1
Insurance type is self-reported from the patient to the pharmacist.  Please note that if the
insurance type was not specified it was not included in this analysis.  Private pay refers to
those that did not pay with insurance.  The blue line indicates an increase in the number of
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4.3 Geographic Location (Prescriber County)
     The average rate of dispensed opioid prescriptions prescribed by SC prescribers has declined from 944.2
per 1,000 people in 2015 to 662.9 per 1,000 people in 2020. From 2015 to 2020, there was a shift in the rate of
opioids in the Pee Dee region of SC. When compared to 2015, fewer counties in the Pee Dee region had a
higher rate of opioid prescriptions compared to the state’s average rate in 2020 (Figure 17 and 18).
Additionally, from 2015 to 2020, the number of opioid prescriptions increased more than 10% in Calhoun and
Barnwell county, while decreasing in 43 other SC counties over time. In 2020, Florence, Charleston,
Darlington, Greenwood, and Greenville county had the highest rate of dispensed opioid prescriptions.
14
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Figure 17.  Rate of opioid prescriptions per 1,000 residents by prescriber county for 2015
Figure 18.  Rate of opioid prescriptions per 1,000 residents by prescriber county for 2020
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V. Stimulants
     Stimulants are a class of
drugs used to increase alertness,
attention, and energy for
conditions such as attention-
deficit hyperactivity disorder
and narcolepsy.  This section
reports on stimulants dispensed
in SC and prescribed by a SC
provider. In 2020, the most
common stimulant prescriptions



































and dextroamphetamine sulfate. From 2015 to 2020, the number of dispensed stimulant prescriptions
increased by 13.26% (1,420,059 to 1,608,376, respectively) (Figure 19). Additionally, the total quantity of
stimulant prescriptions increased by 13.58% during the same time period (Figure 20).























Figure 20.  Total prescription quantity for stimulants over time 1
Prescription quantity is defined as a stimulant in a capsule or tablet form.1 16
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     In 2020, the average age of patients receiving stimulant prescriptions from SC prescribers was
approximately 27. SC has seen an increase over the years in stimulant prescriptions among all age groups
except for those 18-24 (Figure 21). Patients 0-17 years of age continue to be prescribed the majority of
stimulant prescriptions compared to any other age group. Additionally, more males than females received a
stimulant prescription in 2020 (101,382 versus 93,003, respectively). The number of individuals that receive
stimulant prescriptions has increased by 29.34% for females and 8.11% for males from 2015 to 2020. From
2015 to 2020, prescriptions for stimulants from SC practitioners have increased among all payment types
(Figure 22). In addition to commercial insurance, Medicaid continues to be the top form of payment for
patients receiving stimulants. The number of patients filling stimulant prescriptions from SC prescribers
has increased for both in-state and out-of-state patients from 2015 to 2020. In 2020, the number of patients
with a SC address filling a stimulant prescription in SC and from a SC prescriber was 203,460, while the
number of patients with an address outside of SC was 4,836.
5.2 Patient Demographics























Figure 21. Number of filled stimulant prescriptions prescribed by SC
prescribers by patient age 1
Age is self-reported from the patient to the pharmacist.  Please note that if age was
unknown, it was not included in this analysis.  The blue line indicates an increase in the
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Figure 22. Number of filled stimulant prescriptions prescribed by SC
prescribers by patient insurance type 1
Insurance type is self-reported from the patient to the pharmacist.  Please note that if the
insurance type was not specified it was not included in this analysis.  Private pay refers to
those that did not pay with insurance.  The blue line indicates an increase in the number of
prescriptions from 2015, while a gray line indicates a decrease.
1
     The average rate of dispensed stimulant prescriptions prescribed by SC prescribers has increased from
290.3 per 1,000 people in 2015 to 312.4 per 1,000 people in 2020. From 2015 to 2020, there was no difference
observed between the years when comparing the county rate to the state’s average rate of stimulant
prescriptions (Figure 23 and 24). From 2015 to 2020, the following counties experienced a greater than 10%
increase in the number of stimulant prescriptions prescribed by a SC prescriber: Calhoun, Clarendon,
McCormick, Bamberg, Berkeley, Dorchester, Greenville, York, Saluda, Abbeville, Williamsburg, Charleston,
Beaufort, Richland, Dillon, Anderson, Lexington, Kershaw, Horry, Hampton, and Edgefield county. In 2020,
Charleston, Greenville, Richland, Lexington, and Florence county had the highest rate of dispensed
stimulant prescriptions.
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Figure 23.  Rate of stimulant prescriptions per 1,000 residents by prescriber county for 2015
Figure 24.  Rate of stimulant prescriptions per 1,000 residents by prescriber county for 2020
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VI. Summary
     The PMP is evolving as a clinical and public health surveillance tool. As thousands of deaths are
attributed to drug overdoses each year, increasing the usage of the PMP to inform clinical decisions is
instrumental in addressing this public health crisis. The impact of previous and on-going efforts by the SC
PMP can be shown in yearly increases in provider PMP utilization and in the overall decreases in the total
number of controlled substance prescriptions. The Bureau of Drug Control will continue to enhance the
program and provide education to maintain the positive data trends for controlled substances prescribed in
SC.
20
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